Remofuscin® prevented retinal thinning in Stargardt disease patients
Katairo GmbH, a biopharmaceutical company focused on discovering, developing and commercializing novel treatments for ba…
Katairo GmbH, a biopharmaceutical company focused on discovering, developing and commercializing novel treatments for ba…